首页> 外文会议>International Conference on Photodynamic Therapy and Laser Medicine >Study of biological effects of sulfonated chloroaluminum phthalocyanine in a transplantable mouse tumor (S180)
【24h】

Study of biological effects of sulfonated chloroaluminum phthalocyanine in a transplantable mouse tumor (S180)

机译:磺化氯铝酞菁在可移植小鼠肿瘤中的生物学作用研究(S180)

获取原文
获取原文并翻译 | 示例

摘要

Abstract: Sulfonated chloroaluminum phthalocyanine (AlClPCS) has been considered in recent years as a new photosensitizer with promising use in photodynamic therapy (PDT) of cancer. In this work, its biological effects were studied in mice bearing S180 tumors. It was found in tissue distribution measurements that AlClPCS can be selectively accumulated in the tumor, the peak tumor concentration of AlClPCS occurs 36 h after administration, with a tumor:skin ratio of 3:1. The spectral transmittance measurement in the tumor, carried out in vivo at 48 h after administration of AlClPCS at 10 mg/kg, showed that AlClPCS accumulation in the tumor affects the light penetration to some extent at its 675 nm main absorption peak, but the transmittance at 675 nm is still comparable to that at 630 nm, the absorption peak of HPD. The temperature measurement in the tumor showed that the temperature increase is minimal under 100 mw/cm$+2$/ irradiation. The tumor response to AlClPCS photodynamic therapy was encouraging. The cure rate of tumors (20 mice) reached 60% under conditions where the irradiation dose of red light was 180 J/cm$+2$/ and the dose of AlClPCS administration was 10 mg/kg, showing AlClPCS has the potential to become a candidate for clinical photodynamic therapy. !12
机译:摘要:近年来,磺化氯铝酞菁(AlClPCS)被认为是一种新型的光敏剂,有望在癌症的光动力疗法(PDT)中得到应用。在这项工作中,在患有S180肿瘤的小鼠中研究了其生物学作用。在组织分布测量中发现,AlClPCS可以选择性地积聚在肿瘤中,AlClPCS的最大肿瘤浓度出现在给药后36小时,肿瘤与皮肤的比例为3:1。在以10 mg / kg的AlClPCS给药后48小时在体内进行的光谱透射率测量显示,AlClPCS在肿瘤中的积累在其675 nm主吸收峰处在一定程度上影响了光的穿透,但是675 nm处的HPD吸收峰仍与630 nm处的相当。肿瘤中的温度测量结果表明,在100 mw / cm $ + 2 $ /的辐射下,温度升高最小。肿瘤对AlClPCS光动力疗法的反应令人鼓舞。在红光照射剂量为180 J / cm $ + 2 $ /和AlClPCS给药剂量为10 mg / kg的条件下,肿瘤(20小鼠)的治愈率达到60%,这表明AlClPCS有潜力成为临床光动力疗法的候选人。 !12

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号